Genmab — Marts 2020
-
- linje dette her fase 3 - Ikema: https://www.clinicaltrials.gov/ct2/show/NCT03275285?term=isatuximab+mm&draw=2&rank=4
-
Det eneste 1. linje jeg har kunnet finde er dette fase 1: https://www.clinicaltrials.gov/ct2/show/NCT02513186?term=isatuximab+mm&draw=2&rank=2
-
Tak Bulder
-
this NKTCL trial was recently completed; should we expect a Ph III trial to be started? https://clinicaltrials.gov/ct2/show/NCT02927925?term=NKTCL+AND+daratumumab&draw=2&rank=1
-
There were some years ago stories about fantastic outcome for some patients with NKTCL who received dara. But since then it has been quite.
-
Conclusions: DARA 16 mg/kg was well tolerated with no new safety concerns, and only 2 patients discontinuing due to TEAEs. DARA monotherapy demonstrated an encouraging response rate (ORR: 25%) in pts with R/R NKTCL and warrants further study in this poor prognosis pt population. https://ashpublications.org/blood/article/134/Supplement_1/1568/427350/Daratumumab-Monotherapy-for-Patients-with-Relapsed
-
Genmab is proud to be on the 2020NJBIZ BestPlacesNJ to work list: https://njbiz.com/best-places-to-work-in-nj-2020/
-
-
Se seneste slide ware fra Genmab side 33. DR5/DR5 er MEGET potent https://ir.genmab.com/static-files/50a5c114-5126-45a8-9d6f-17b883705a16
-
Øhh Bongobob er det godt? Potent ja, men patienten tages ud pga. bivirkninger?
-
Lars Tvede: https://www.proinvestor.com/debat/82383
-
Godt med dansk pharma i en krise tid: https://twitter.com/NordicStock/status/1236359334365454341
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind